Proqr Therapeutics Bv Stock Probability of Future Stock Price Finishing Under 1.61
| PRQR Stock | USD 3.44 0.10 2.82% |
ProQR |
ProQR Therapeutics Target Price Odds to finish below 1.61
The tendency of ProQR Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 1.61 or more in 90 days |
| 3.44 | 90 days | 1.61 | about 12.74 |
Based on a normal probability distribution, the odds of ProQR Therapeutics to drop to $ 1.61 or more in 90 days from now is about 12.74 (This ProQR Therapeutics BV probability density function shows the probability of ProQR Stock to fall within a particular range of prices over 90 days) . Probability of ProQR Therapeutics price to stay between $ 1.61 and its current price of $3.44 at the end of the 90-day period is about 65.72 .
Given the investment horizon of 90 days the stock has the beta coefficient of 3.26 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, ProQR Therapeutics will likely underperform. Moreover ProQR Therapeutics BV has an alpha of 1.0692, implying that it can generate a 1.07 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). ProQR Therapeutics Price Density |
| Price |
Predictive Modules for ProQR Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ProQR Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.ProQR Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. ProQR Therapeutics is not an exception. The market had few large corrections towards the ProQR Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold ProQR Therapeutics BV, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ProQR Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.07 | |
β | Beta against Dow Jones | 3.26 | |
σ | Overall volatility | 0.95 | |
Ir | Information ratio | 0.09 |
ProQR Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ProQR Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ProQR Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| ProQR Therapeutics is way too risky over 90 days horizon | |
| ProQR Therapeutics appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 6.51 M. Net Loss for the year was (27.54 M) with profit before overhead, payroll, taxes, and interest of 4.8 M. | |
| About 14.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: ProQR Therapeutics Shares Cross Above 50 Day Moving Average - Time to Sell - MarketBeat |
ProQR Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of ProQR Stock often depends not only on the future outlook of the current and potential ProQR Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ProQR Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 81 M | |
| Cash And Short Term Investments | 118.9 M |
ProQR Therapeutics Technical Analysis
ProQR Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. ProQR Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of ProQR Therapeutics BV. In general, you should focus on analyzing ProQR Stock price patterns and their correlations with different microeconomic environments and drivers.
ProQR Therapeutics Predictive Forecast Models
ProQR Therapeutics' time-series forecasting models is one of many ProQR Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary ProQR Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about ProQR Therapeutics
Checking the ongoing alerts about ProQR Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for ProQR Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| ProQR Therapeutics is way too risky over 90 days horizon | |
| ProQR Therapeutics appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 6.51 M. Net Loss for the year was (27.54 M) with profit before overhead, payroll, taxes, and interest of 4.8 M. | |
| About 14.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: ProQR Therapeutics Shares Cross Above 50 Day Moving Average - Time to Sell - MarketBeat |
Additional Tools for ProQR Stock Analysis
When running ProQR Therapeutics' price analysis, check to measure ProQR Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProQR Therapeutics is operating at the current time. Most of ProQR Therapeutics' value examination focuses on studying past and present price action to predict the probability of ProQR Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProQR Therapeutics' price. Additionally, you may evaluate how the addition of ProQR Therapeutics to your portfolios can decrease your overall portfolio volatility.